NCT06893510Recruiting
Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia
The Effect of Virtual Reality-Based and Face-to-Face Relaxation Programs on Maternal and Fetal Outcomes in Pregnant Women With Preeclampsia
Source: ClinicalTrials.gov · Last updated 10 Jun 2026
Brief summary (registry, in English)
Preeclampsia, affecting 2-8% of pregnancies globally, is a leading hypertensive disorder in pregnancy. It is clinically characterized by elevated blood pressure (≥140/90 mmHg) after the 20th gestational week, often accompanied by proteinuria and systemic complications such as thrombocytopenia, liver dysfunction, and cerebral symptoms. This condition poses significant risks for both maternal and fetal health, increasing the likelihood of organ damage, preterm birth, and long-term cardiovascular and neurodevelopmental complications. Non-pharmacological interventions, including relaxation techniques, have been explored for symptom management. Progressive muscle relaxation (PMR) has shown efficacy in reducing stress, anxiety, and blood pressure. Recently, virtual reality (VR)-based relaxation techniques have gained attention for enhancing stress relief and improving health outcomes. This study aims to compare the effects of VR-based PMR with in-person PMR on maternal and fetal outcomes in preeclamptic pregnancies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- First submitted
- 12 Mar 2025
- Start date
- 8 Sept 2025
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Istanbul University - Cerrahpasa
- NCT number
- NCT06893510
What you commit to
- Study type: Interventional
- Planned participants: 96
- From 8 Sept 2025 to the primary completion date, 1 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hearing or vision impairment in the pregnant individual.
- HELLP Syndrome or Eclampsia.
- History of vertigo.
- Withdrawal Criteria:
- Participants whose general health condition deteriorates during the intervention.
Other
- Multiple pregnancy.
- Pregnancy achieved through assisted reproductive technologies.
- Fetal distress requiring emergency intervention.
- Cases where live birth does not occur.
- Participants who voluntarily withdraw from the study.
- Participants experiencing side effects from virtual reality headset use (e.g., dizziness, nausea, headache).
- Participants who do not practice progressive muscle relaxation at least once a week after the intervention.
Who the study is looking for
- Hospitalized with a diagnosis of preeclampsia.
- Gestational age ≥26 weeks.
- 18 years or older.
- Singleton and viable pregnancy.
- Willing to participate in the study voluntarily.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ümraniye Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.